HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

2-Deoxyglucose

HCID 108223
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
154-17-6
Standard SMILES
O=CC[C@@H](O)[C@H](O)[C@H](O)CO
InChIKey
VRYALKFFQXWPIH-PBXRRBTRSA-N
Molecular formula
C6H12O5
Average molar mass
164.16 g/mol
Monoisotopic mass
164.06847348

Overview

2-deoxyglucose is predominantly used as a diagnostic agent in its radiolabelled form (fluorine-18 is used as the radiolabel). By using positron emission tomography (PET), radiolabelled 2-deoxyglucose can determine glucose metabolism, which is altered in diseases such as cardiovascular disease, tumors, and Alzheimer's disease. Therapeutically, 2-deoxyglucose is an investigational drug that is being studied as an anticancer and antiviral agent. Concerning the former, 2- deoxyglucose was used as an adjunct to chemotherapy and radiotherapy in the treatment of solid tumors (lung, breast, pancreas, head, neck, and gastric tumors). The exact mechanisms of action of 2-deoxyglucose is still being investigated, but it is known that in hypoxic cancer cells, 2-deoxyglucose is a glycolysis inhibitor that prevents ATP production and, ultimately, cell survival. With respect to antiviral therapy, 2-deoxyglucose was shown to be effective against herpes simplex virus by affecting the virus' ability to penetrate cells. As an experimental drug, 2-deoxyglucose was demonstrated to work as an anticonvulsant in temporal lobe epilepsy. In this condition, 2-deoxyglucose represses the expression of certain proteins that are at high levels after a seizure. Although there are several possible therapeutic indications for 2-deoxyglucose, presently there is no approved indication for 2-deoxyglucose as a therapeutic agent.

Names & identifiers

Preferred name
2-Deoxyglucose
IUPAC
(3R,4S,5R)-3,4,5,6-tetrahydroxyhexanal
English name
2-Deoxy-D-glucose
Molecular formula
C6H12O5
Molecular weight
164.16

Names & synonyms

2-deoxy-D-glucose154-17-6Deoxyglucose(3R,4S,5R)-3,4,5,6-tetrahydroxyhexanal2-Desoxy-D-glucose2-Deoxy-D-mannoseD-2-DeoxyglucoseD-arabino-2-desoxyhexose2 Deoxyglucose2 Deoxy D glucose2 Desoxy D glucoseD-Arabino-hexose, 2-deoxy-
Show more names
2-dg2-DEOXYGLUCOSE2-Dexoy-D-GlucoseD-Arabino-2-deoxyhexose2-deoxy-d-[UL-13C6]glucose(4R,5S,6R)-6-(Hydroxymethyl)tetrahydro-2H-pyran-2,4,5-triolba2758
9G2MP84A8WDTXSID1037648GlyTouCan:G23624QENSC 15193BA-2758NSC-15193RefChem:471277CHEBI:15866

Database identifiers

CAS
154-17-6、61-58-5
PubChem CID
108223
DTXSID
DTXSID1037648
ChEMBL
CHEMBL1880349、CHEMBL2074932
UNII
9G2MP84A8W

Properties

Computed structural properties

XLogP
-2.9
Topological polar surface area
98 Ų
Hydrogen bond donors
4
Hydrogen bond acceptors
5
Rotatable bonds
5
Heavy atoms
11
Formal charge
0
Complexity
116

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
Boiling PointDecomposes
Melting Point147°C (296.6°F)
Collision Cross Section136.7 Ų [M+Na]+ [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]

Physicochemical properties

Melting point
146 · 146-147 °C(lit.)
alpha
45.5 · 45.5 º (c=2, H2O)
Boiling point
211.61 °C · 211.61°C (rough estimate)
Density
1.1738 · 1.1738 (rough estimate)
refractive index
46.5 ° · 46.5 ° (C=1, H2O)
storage temp.
2 · 2-8°C
solubility
2 O: · H2O: 50 mg/mL, clear, colorless to faintly yellow
form
crystalline

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 3 items

This chemical does not meet GHS hazard criteria for 100% (2 of 2) of all reports.

Not Classified

Aggregated GHS information provided per 2 reports by companies from 1 notifications to the ECHA C&L Inventory.

Hazard information

Regulatory Information · 2 items

Chemical: D-arabino-Hexose, 2-deoxy-

D-arabino-Hexose, 2-deoxy-: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - D-arabino-Hexose, 2-deoxy-: Environment tier I assessment
Hazard Classes and CategoriesNot Classified

Toxicology

Interactions · 5 items

2-DEOXYGLUCOSE INJECTED INTRAPERITONEALLY IN RATS IN LARGE DOSES CAUSED CHANGES IN THE ELECTRORETINOGRAM CONSISTING OF A DECR IN BOTH ALPHA- AND BETA-WAVES. THE EFFECT WAS ANTAGONIZED BY D-GLUCOSE.

SIMULTANEOUS ADMIN OF GLUCOSE @ DOSE EXCEEDING ITS MAX TUBULAR TRANSPORT CAPACITY INHIBITED TUBULAR REABSORPTION OF 2-DEOXYGLUCOSE. THUS, THE PROCESS OF TUBULAR REABSORPTION IS PROBABLY THE SAME AS THAT FOR GLUCOSE.

IN ANESTROUS SHEEP, 2-DEOXYGLUCOSE INFUSION INHIBITED LH RELEASE INDUCED BY ESTRADIOL BUT NOT BY LH-RH.

2-DEOXY-D-GLUCOSE INHIBITED REPAIR OF POTENTIALLY LETHAL DAMAGE INDUCED BY X-RAYS IN MOUSE EHRLICH ASCITES TUMOR CELLS.

For more Interactions (Complete) data for 2-DEOXY-D-GLUCOSE (6 total), please visit the HSDB record page.

Non-Human Toxicity Excerpts

Chemistry & industry

Pharmacology

PharmacodynamicsPhysiologically 2-deoxyglucose is an inhibitor of glycolysis, certain viruses, and seizures.
Mechanism of Action · 1 item

Solid tumors have hypoxic areas with slow growing cells that are resistant to chemotherapy, which attacks rapidly dividing cells. In the hypoxic area of the tumor, the cells rely on anaerobic glycolysis to produce energy in the form of ATP while non-tumor cells can rely on additional pathways such as fatty acid and amino acid metabolism to produce ATP. 2-deoxyglucose is an inhibitor of glycolysis because as a modified glucose molecule (it has a hydrogen at the carbon 2 position instead of a hydroxyl group), it is unable to complete the glycolysis process, and as such will hinder the survival of slow growing cancer cells. Regarding 2-deoxyglucose's antiviral activity, it prevents the glycosylation of specific proteins and lipids as well as prevents proper penetration of the virus into the target cells. In temporal lobe epilepsy, 2-deoxyglucose represses the overactive brain-derived neurotrophic factor (BDNF) promoter and prevents the increased expression of BDNF protein and TrkB receptor (BDNF's receptor) that is observed in epileptic patients.

Metabolism/Metabolites2-DEOXY-D-GLUCOSE WAS CONVERTED TO THE 6-PHOSPHATE IN MOUSE TESTIS AND LIVER AFTER IP INJECTION OF 50 MG/KG BODY WT DAILY FOR 7 DAYS.
MeSH Pharmacological Classification · 2 items

Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033)

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.

Absorption, Distribution and Excretion · 1 item

WHEN THE RENAL EXCRETION OF 2-DEOXYGLUCOSE WAS STUDIED IN DOGS AND RATS BY CONVENTIONAL CLEARANCE AND STOP-FLOW TECHNIQUES, IT WAS REABSORBED BY THE RENAL TUBULES AT AN AVG OF 68-89% OF THE FILTERED LOADS AND THE REABSORPTION SITE WAS IN THE PROXIMAL TUBULES.

Related reactions

14 records
New reaction record
HRID 276096 reaction equation
HRID 276096As reactant
HRID 390422 reaction equation
HRID 390422As reactant
HRID 548538 reaction equation
HRID 548538As product
HRID 729203 reaction equation
HRID 729203As product
HRID 882657 reaction equation
HRID 882657As product
HRID 1353987 reaction equation
HRID 1353987As product
HRID 1434490 reaction equation
HRID 1434490As product
HRID 1765917 reaction equation
HRID 1765917As product
PreviousPage 1 of 2

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
EC Number
205-823-0
Nikkaji
J59.831C
pka
1 · pK1:12.52 (25°C)
color
white
biological source
synthetic
optical activity
38.5 · +38.5 → +45.9
Water Solubility
Soluble in water.
Merck
14 · 14,2904
BRN
1723331 · 1723331
Stability
1 year · Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 1 month. Solutions in water are not stable and must be used within 1 working day.
InChI
1S/C6H12O5/c7-2-1-4(9)6(11)5(10)3-8/h2,4-6,8-11H,1,3H2/t4-,5-,6+/m1/s1
InChIKey
PMMURAAUARKVCB-CEZCPVKQSA-N
SMILES
OC[C@@H](O)[C@@H](O)[C@H](O)CC=O
LogP
-1.46 · -1.460 (est)
CAS DataBase Reference
154 · 154-17-6(CAS DataBase Reference)
EWG's Food Scores
1 · 1
FDA UNII
9 G2MP84A8W · 9G2MP84A8W
EPA Substance Registry System
2 · D-arabino-Hexose, 2-deoxy- (154-17-6)
UNSPSC Code
12352201 · 12352201
NACRES
79 · NA.79
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
315 · H315-H319
Precautionary statements
264 · P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313
PPE
95 · Eyeshields, Gloves, type N95 (US)
Hazard Codes
Xn,Xi
Risk Statements
20 · 20/21/22-36/37/38
Safety Statements
24 · 24/25-37/39-36-26
WGK Germany
3 · 3
RTECS
3325000 · MQ3325000
F
3 · 3-10
TSCA
TSCA listed
HS Code
29400090 · 29400090
Storage Class
11 · 11 - Combustible Solids
Hazardous Substances Data
154 · 154-17-6(Hazardous Substances Data)
· 5 items

2-DEOXYGLUCOSE INJECTED INTRAPERITONEALLY IN RATS IN LARGE DOSES CAUSED CHANGES IN THE ELECTRORETINOGRAM CONSISTING OF A DECR IN BOTH ALPHA- AND BETA-WAVES.

...120 MG/DAY /GIVEN TO RAT/ FROM THE 9TH THROUGH THE 20TH GESTATIONAL DAY... RESORPTIONS WERE 69% AND THE SURVIVING FETUSES WERE ALL MALFORMED. ANOPHTHALMIA, CLEFT LIP AND PALATE AND LESIONS OF THE EXTREMITIES WERE OBSERVED. ...GAVE 1 G/KG ON DAYS 8, 9, 10 OR 11 & FOUND NO MALFORMATIONS IN SURVIVING RAT FETUSES.

2-DEOXY-D-GLUCOSE (DGLC) SELECTIVELY INHIBITED VIRUS DNA SYNTHESIS IN HUMAN EMBRYONIC LUNG CELLS INFECTED WITH HUMAN CYTOMEGALOVIRUS (HCMV). THE EFFECTIVE CONCN OF DGLC WAS APPROX 10-FOLD HIGHER IN CULTURE MEDIUM CONTAINING GLUCOSE INSTEAD OF SODIUM PYRUVATE. VIRUS DNA SYNTHESIS COULD BE SELECTIVELY INHIBITED BY ADDN OF DGLC EVEN AFTER INITIATION OF HCMV DNA REPLICATION. APPARENTLY, DGLC INTERFERES WITH THE FUNCTION OF AN EARLY CHROMATIN-ASSOCIATED GLYCOPROTEIN ESSENTIAL FOR VIRUS DNA SYNTHESIS.

2-DEOXY-D-GLUCOSE (0.3-1.2 MOL) INJECTED INTO THE 3RD VENTRICLE OF RATS DEPRESSED APPETITE FOR 72 HR. THE BLOOD SUGAR WAS INCR FOR 48 HR, WHILE FREE FATTY ACID INITIALLY INCR BUT DECR BY 24 HR.

For more Non-Human Toxicity Excerpts (Complete) data for 2-DEOXY-D-GLUCOSE (7 total), please visit the HSDB record page.

Safety data

F
3-10
PPE
Eyeshields, Gloves, type N95 (US)
wgk
3
tsca
TSCA listed
rtecs
MQ3325000
hs_code
29400090
risk_code
20/21/22-36/37/38
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn,Xi
safety_code
24/25-37/39-36-26
Storage Class
11 - Combustible Solids
Hazard statements
H315-H319
Precautionary statements
P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313
Hazardous Substances Data
154-17-6(Hazardous Substances Data)

Uses & manufacturing

Uses · 3 items

2-DEOXYGLUCOSE IS A GLUCOSE ANTIMETABOLITE, INHIBITING GLYCOLYSIS; IT IS A WIDELY USED RESEARCH TOOL TO STUDY GLUCOSE-DEPENDENT OR -MEDIATED REACTIONS

RESEARCH CHEMICAL

MEDICATION (VET)

U.S. Exports · 2 items

(1979) No Data

(1981) No Data

U.S. Imports · 2 items

(1979) No Data

(1981) No Data

U.S. Production · 2 items

(1979) No Data

(1981) No Data

Consumption PatternsESSENTIALLY 100% AS A RESEARCH CHEMICAL
General Manufacturing Information · 2 items

D-arabino-Hexose, 2-deoxy-: ACTIVE

THE DEOXYSUGARS SUCH AS 2-DEOXYGLUCOSE ARE POTENT HERBICIDES. 2-DEOXYGLUCOSE SPRAYED AT 100 G/ACRE COMPLETELY CONTROLLED PLANTAGO ASIATICA IN AGROPYRON KAMOCHI AND ELEUSINE INDICA.

Applications · 3 items

Description2-Deoxy-D-glucose (154-17-6) is a synthetic glucose analog with extensive biological effects. It is commonly thought of as an inhibitor of glycolysis, but its metabolic effects are wide-ranging. 2-Deoxy-D-glucose competitively inhibits glucose uptake via its metabolite 2-Deoxy-D-glucose-6-phosphate, which inhibits hexokinase and phosphoglucose-isomerase leading to decreased ATP production, cell cycle blockage, decreased cell growth and ultimately cell death.1,2

Uses2-deoxy-D-Glucose is a non-metabolizable glucose analog that inhibits phosphorylation of glucose by hexokinase, the first step of glycolysis. This results in the depletion in cellular ATP, the inhibition of protein glycosylation, and the disruption of ER quality control by inducing the unfolded protein response. 2-deoxy-D-Glucose has been shown to cause cell cycle inhibition and cell death in in vitro models of hypoxia, induce autophagy, increase reactive oxygen species production, activate AMPK, and block tumor cell growth in animal models.[Cayman Chemical]

Uses2-Deoxy-D-glucose (2-DG) is used in glucoprivic feeding research to invoke and study the processes of counter-regulatory response (CRR). 2-Deoxy-D-glucose is used in the development of anti-cancer strategies that involve radio- and chemosensitization and oxidative stress.

Upstream & downstream products

Upstream raw materials

D-threo-Hexos-5-ulose, cyclic 1-(1,3-propanediyl acetal) (9CI)D-arabino-Hexose, 2-deoxy-, cyclic 1,3-propanediyl acetal (9CI)D-arabino-Heptose, 2,3-dideoxy-4,5:6,7-bis-O-(1-methylethylidene)-